AR064258A1 - Inhibidores macrociclicos del virus de hepatitis c - Google Patents
Inhibidores macrociclicos del virus de hepatitis cInfo
- Publication number
- AR064258A1 AR064258A1 ARP070105116A ARP070105116A AR064258A1 AR 064258 A1 AR064258 A1 AR 064258A1 AR P070105116 A ARP070105116 A AR P070105116A AR P070105116 A ARP070105116 A AR P070105116A AR 064258 A1 AR064258 A1 AR 064258A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- cycloalkyl
- hydrogen
- optionally substituted
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Inhibidores de la replicacion de VHC de la formula (1) y las sales y estereoisomeros de los mismos, donde cada línea de guiones (representada por----) representa un enlace doble opcional; X es N, CH y donde X porta un enlace doble, éste de C; R1 es - OR7, -NH-SO2R8 R2 es hidrogeno y donde X es C o CH, R2 también puede ser alquilo C1-8; R3 es hidrogeno, alquilo C1-6, alcoxi C1-6 alquilo C1-6, ciclolalquilo C3-7; n es 3, 4, 5 o 6; R4 es alquilo C1-6 o cicloalquilo C3-7; R5 es hidrogeno, halo, alquilo C1-6, hidroxi, alcoxi C1-6, polihaloalquilo C1-6; R6 es hildrogeno, alcoxi C1-6, mono-o-dialquilamino C1-6; o R5 y R6 pueden formar un anillo insaturado o parcialmente insaturado de 5 o 6 miembros, que comprenden opcionalmente uno o dos seleccionados de O, N y S; R7 es hidrogeno; cicloalquilo C3-7, opcionalmente sustituido con alquilo C1-6; o alquilo C1-6 opcionalmente sustituido con cicloalquilo C3-7; R8 es cicloalquilo C3-7, opcionalmente sustituido con alquilo C1-6; alquilo C1-6 opcionalmente sustituido con cicloalquilo C3-7 o -NR8aR8b; R8a y R8b son alquilo C1-6, o ambos pueden formar un anillo heterocíclico saturado de 5 o 6 miembros; composiciones farmacéuticas que contienen los compuestos (1) y procesos para preparar dichos compuestos (1).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06124359 | 2006-11-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR064258A1 true AR064258A1 (es) | 2009-03-25 |
Family
ID=37894415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070105116A AR064258A1 (es) | 2006-11-17 | 2007-11-16 | Inhibidores macrociclicos del virus de hepatitis c |
Country Status (17)
Country | Link |
---|---|
US (2) | US8637663B2 (es) |
EP (1) | EP2097402B1 (es) |
JP (2) | JP2010510192A (es) |
KR (1) | KR20090079881A (es) |
CN (1) | CN101535294B (es) |
AR (1) | AR064258A1 (es) |
AU (1) | AU2007321182B2 (es) |
BR (1) | BRPI0718798A2 (es) |
CA (1) | CA2661338C (es) |
CL (1) | CL2007003299A1 (es) |
DK (1) | DK2097402T3 (es) |
EA (1) | EA200970493A1 (es) |
ES (1) | ES2470568T3 (es) |
HK (1) | HK1136824A1 (es) |
MX (1) | MX2009005219A (es) |
TW (1) | TWI406660B (es) |
WO (1) | WO2008059046A1 (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY140680A (en) | 2002-05-20 | 2010-01-15 | Bristol Myers Squibb Co | Hepatitis c virus inhibitors |
CN101273030B (zh) * | 2005-07-29 | 2012-07-18 | 泰博特克药品有限公司 | 丙型肝炎病毒的大环抑制剂 |
CA2661338C (en) * | 2006-11-17 | 2015-05-12 | Tibotec Pharmaceuticals Ltd. | Macrocyclic inhibitors of hepatitis c virus |
CL2008001274A1 (es) * | 2007-05-03 | 2008-11-03 | Intermune Inc Y Array Biopharma Inc | Compuestos macrolidos derivados de 5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahidrociclopropan[e]pirrolo[1,2-a][1,4]diazaciclopentadecinilo, inhibidores de la actividad de la proteasa ns3-ns4; su procedimiento de preparacion; composicion farmaceutica; compuestos intermediarios y procedimiento de preparacion; y uso en el tratamiento de..... |
BRPI0811447A2 (pt) * | 2007-05-10 | 2014-10-29 | Intermune Inc | Compostos, composição farmacêutica e métodos de inibição da atividade da protease ns3/ns4, de tratamento da fibrose hepática e de intensificação da função hepática num indivíduo tendo infecção de vírus da hepatite c. |
US8048862B2 (en) * | 2008-04-15 | 2011-11-01 | Intermune, Inc. | Macrocyclic inhibitors of hepatitis C virus replication |
US8207341B2 (en) | 2008-09-04 | 2012-06-26 | Bristol-Myers Squibb Company | Process or synthesizing substituted isoquinolines |
UY32099A (es) | 2008-09-11 | 2010-04-30 | Enanta Pharm Inc | Inhibidores macrocíclicos de serina proteasas de hepatitis c |
AR075584A1 (es) | 2009-02-27 | 2011-04-20 | Intermune Inc | COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO. |
US8377962B2 (en) | 2009-04-08 | 2013-02-19 | Idenix Pharmaceuticals, Inc. | Macrocyclic serine protease inhibitors |
TW201117812A (en) | 2009-08-05 | 2011-06-01 | Idenix Pharmaceuticals Inc | Macrocyclic serine protease inhibitors |
WO2011038293A1 (en) * | 2009-09-28 | 2011-03-31 | Intermune, Inc. | Cyclic peptide inhibitors of hepatitis c virus replication |
WO2011063502A1 (en) * | 2009-11-24 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Hepatitis c inhibitor compounds |
PL2528922T3 (pl) | 2010-01-27 | 2018-01-31 | Ab Pharma Ltd | Związki poliheterocykliczne jako inhibitory hcv |
BR112013016480A2 (pt) | 2010-12-30 | 2016-09-20 | Abbvie Inc | macrocíclo da fenantridina inibadores da protease da serina da hepatite c |
JP2014502620A (ja) | 2010-12-30 | 2014-02-03 | エナンタ ファーマシューティカルズ インコーポレイテッド | 大環状c型肝炎セリンプロテアーゼ阻害剤 |
US9353100B2 (en) | 2011-02-10 | 2016-05-31 | Idenix Pharmaceuticals Llc | Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections |
US8957203B2 (en) | 2011-05-05 | 2015-02-17 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
US8691757B2 (en) | 2011-06-15 | 2014-04-08 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
WO2012171332A1 (zh) | 2011-06-16 | 2012-12-20 | 爱博新药研发(上海)有限公司 | 抑制丙型肝炎病毒的大环状杂环化合物及其制备和应用 |
JP6154474B2 (ja) | 2012-10-19 | 2017-06-28 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | C型肝炎ウイルス阻害剤 |
US9643999B2 (en) | 2012-11-02 | 2017-05-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
WO2014070964A1 (en) | 2012-11-02 | 2014-05-08 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
WO2014071007A1 (en) | 2012-11-02 | 2014-05-08 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
US9409943B2 (en) | 2012-11-05 | 2016-08-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US9580463B2 (en) | 2013-03-07 | 2017-02-28 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
CN104557954A (zh) * | 2013-10-16 | 2015-04-29 | 上海唐润医药科技有限公司 | 抗hcv的大环化合物 |
EP3089757A1 (en) | 2014-01-03 | 2016-11-09 | AbbVie Inc. | Solid antiviral dosage forms |
JP7208074B2 (ja) | 2019-03-19 | 2023-01-18 | Ntn株式会社 | 出力電圧検出回路 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5087876A (en) | 1990-07-16 | 1992-02-11 | Semitest, Inc. | Apparatus and method for making surface photovoltage measurements of a semiconductor |
EP0674513B1 (en) | 1992-12-29 | 1996-09-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
IL110752A (en) | 1993-09-13 | 2000-07-26 | Abbott Lab | Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor |
US5559158A (en) | 1993-10-01 | 1996-09-24 | Abbott Laboratories | Pharmaceutical composition |
IL111991A (en) | 1994-01-28 | 2000-07-26 | Abbott Lab | Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent |
US6037157A (en) | 1995-06-29 | 2000-03-14 | Abbott Laboratories | Method for improving pharmacokinetics |
US5807876A (en) | 1996-04-23 | 1998-09-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of IMPDH enzyme |
US6054472A (en) | 1996-04-23 | 2000-04-25 | Vertex Pharmaceuticals, Incorporated | Inhibitors of IMPDH enzyme |
CN1116288C (zh) | 1996-04-23 | 2003-07-30 | 沃泰克斯药物股份有限公司 | 用作肌苷-5'-一磷酸脱氢酶抑制剂的脲衍生物 |
PT966465E (pt) | 1997-03-14 | 2003-11-28 | Vertex Pharma | Inibidores do enzima imfdh |
US6323180B1 (en) | 1998-08-10 | 2001-11-27 | Boehringer Ingelheim (Canada) Ltd | Hepatitis C inhibitor tri-peptides |
KR100652535B1 (ko) | 1999-03-19 | 2006-12-01 | 버텍스 파마슈티칼스 인코포레이티드 | Impdh 효소의 억제제 |
UA74546C2 (en) | 1999-04-06 | 2006-01-16 | Boehringer Ingelheim Ca Ltd | Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition |
SV2003000617A (es) | 2000-08-31 | 2003-01-13 | Lilly Co Eli | Inhibidores de la proteasa peptidomimetica ref. x-14912m |
US7273885B2 (en) | 2002-04-11 | 2007-09-25 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
US7125845B2 (en) | 2003-07-03 | 2006-10-24 | Enanta Pharmaceuticals, Inc. | Aza-peptide macrocyclic hepatitis C serine protease inhibitors |
DE602005017582D1 (en) * | 2004-01-30 | 2009-12-24 | Medivir Ab | Hcv ns-3 serine protease inhibitoren |
UY29016A1 (es) * | 2004-07-20 | 2006-02-24 | Boehringer Ingelheim Int | Analogos de dipeptidos inhibidores de la hepatitis c |
CN101273030B (zh) * | 2005-07-29 | 2012-07-18 | 泰博特克药品有限公司 | 丙型肝炎病毒的大环抑制剂 |
PE20070210A1 (es) * | 2005-07-29 | 2007-04-16 | Tibotec Pharm Ltd | Compuestos macrociclicos como inhibidores del virus de hepatitis c |
US7700552B2 (en) * | 2005-07-29 | 2010-04-20 | Medivir Ab | Macrocyclic inhibitors of hepatitis C virus |
PE20070211A1 (es) * | 2005-07-29 | 2007-05-12 | Medivir Ab | Compuestos macrociclicos como inhibidores del virus de hepatitis c |
PT1912997E (pt) | 2005-07-29 | 2011-12-19 | Tibotec Pharm Ltd | Inibidores macrocíclicos do vírus da hepatite c |
PE20070343A1 (es) * | 2005-07-29 | 2007-05-12 | Medivir Ab | Inhibidores macrociclicos del virus de la hepatitis c |
CA2661338C (en) * | 2006-11-17 | 2015-05-12 | Tibotec Pharmaceuticals Ltd. | Macrocyclic inhibitors of hepatitis c virus |
-
2007
- 2007-11-16 CA CA2661338A patent/CA2661338C/en not_active Expired - Fee Related
- 2007-11-16 JP JP2009536740A patent/JP2010510192A/ja not_active Withdrawn
- 2007-11-16 DK DK07822656.0T patent/DK2097402T3/da active
- 2007-11-16 ES ES07822656.0T patent/ES2470568T3/es active Active
- 2007-11-16 AU AU2007321182A patent/AU2007321182B2/en not_active Ceased
- 2007-11-16 WO PCT/EP2007/062436 patent/WO2008059046A1/en active Application Filing
- 2007-11-16 EP EP07822656.0A patent/EP2097402B1/en active Active
- 2007-11-16 KR KR1020097006652A patent/KR20090079881A/ko active IP Right Grant
- 2007-11-16 CL CL200703299A patent/CL2007003299A1/es unknown
- 2007-11-16 MX MX2009005219A patent/MX2009005219A/es active IP Right Grant
- 2007-11-16 AR ARP070105116A patent/AR064258A1/es unknown
- 2007-11-16 CN CN200780042755.6A patent/CN101535294B/zh not_active Expired - Fee Related
- 2007-11-16 TW TW096143432A patent/TWI406660B/zh not_active IP Right Cessation
- 2007-11-16 BR BRPI0718798-0A2A patent/BRPI0718798A2/pt not_active IP Right Cessation
- 2007-11-16 US US12/441,812 patent/US8637663B2/en not_active Expired - Fee Related
- 2007-11-16 EA EA200970493A patent/EA200970493A1/ru unknown
-
2010
- 2010-03-01 HK HK10102144.9A patent/HK1136824A1/xx not_active IP Right Cessation
-
2013
- 2013-12-20 US US14/135,826 patent/US9365582B2/en not_active Expired - Fee Related
-
2014
- 2014-05-08 JP JP2014096884A patent/JP6153495B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US9365582B2 (en) | 2016-06-14 |
US20100022578A1 (en) | 2010-01-28 |
BRPI0718798A2 (pt) | 2013-12-03 |
CA2661338C (en) | 2015-05-12 |
ES2470568T3 (es) | 2014-06-24 |
AU2007321182B2 (en) | 2013-11-14 |
US8637663B2 (en) | 2014-01-28 |
EA200970493A1 (ru) | 2009-10-30 |
CL2007003299A1 (es) | 2008-08-22 |
JP2014221756A (ja) | 2014-11-27 |
AU2007321182A1 (en) | 2008-05-22 |
DK2097402T3 (da) | 2014-06-30 |
KR20090079881A (ko) | 2009-07-22 |
CA2661338A1 (en) | 2008-05-22 |
JP2010510192A (ja) | 2010-04-02 |
HK1136824A1 (en) | 2010-07-09 |
CN101535294A (zh) | 2009-09-16 |
CN101535294B (zh) | 2014-09-24 |
EP2097402B1 (en) | 2014-04-09 |
MX2009005219A (es) | 2009-05-27 |
JP6153495B2 (ja) | 2017-06-28 |
US20140113929A1 (en) | 2014-04-24 |
WO2008059046A1 (en) | 2008-05-22 |
TW200838529A (en) | 2008-10-01 |
EP2097402A1 (en) | 2009-09-09 |
TWI406660B (zh) | 2013-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR064258A1 (es) | Inhibidores macrociclicos del virus de hepatitis c | |
NI200800036A (es) | Inhibidores macrociclicos del virus de la hepatitis c | |
AR081653A1 (es) | Inhibidores del virus de la hepatitis c | |
AR054882A1 (es) | Inhibidores macrociclicos del virus de la hepatitis c | |
CL2020001919A1 (es) | Inhibidores de endonucleasa cap-dependientes. | |
CO6321244A2 (es) | Pirrolopiridinas como inhibidores de cinasa | |
PE20121479A1 (es) | Inhibidores del virus de la hepatitis c | |
AR058546A1 (es) | Derivados de 2- adamantilurea como inhibidores selectivos de 11 beta - hsd1 | |
AR039403A1 (es) | Derivados de acil-4-carboxifenilurea y su uso como antidiabetico | |
AR033295A1 (es) | Compuestos biciclicos de pirimidina, proceso para su obtencion, uso de los mismos para la preparacion de una composicion farmaceutica y dicha composicion farmaceutica | |
ECSP045369A (es) | Derivados de n-[fenil(piperidin-2-il)metil]benzamida, su preparacion y su aplicacion en terapeutica | |
AR063684A1 (es) | Derivados de 4, 4´-bifenildiilbis(1h-imidazol-5, 2-diil) como inhibidores del virus de la hepatitis c, composicion que los comprende y su uso para tratar una infeccion con vhc. | |
AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
AR047076A1 (es) | Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas | |
ES2530943T3 (es) | Derivados de la cromenona con actividad antitumoral | |
AR055150A1 (es) | Compuestos de isoindol - imido y composiciones que los comprenden y sus metodos de uso | |
AR055878A1 (es) | Derivados de ciclopropanocarboxamida | |
AR072166A1 (es) | Derivado de piperidina y su uso como inhibidor de renina superior | |
AR055041A1 (es) | Tiadiazoles y oxadiazoles como inhibidores de la sintesis de leucotrienos. composiciones farmaceuticas. | |
AR059328A1 (es) | Derivados de antranilamida-2-amino-heteroareno-carboxamida, un proceso para su obtencion, composiciones farmaceuticas que los contienen y el uso de estos compuestos para la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por cetp | |
AR037181A1 (es) | Compuesto de 4-heteroaril-(5-miembros) acil pirrolidina, formulacion farmaceutica que lo comprende, uso del mismo para preparar un medicamento y procedimiento para su preparacion | |
AR041395A1 (es) | Compuesto de piridina composicion farmaceutica que lo comprende y su uso para prepararla | |
AR062827A1 (es) | Inhibidores virales policiclicos, una composicion farmaceutica que los comprende y su uso en la preparacion de medicamentos para el tratamiento de una infeccion viral mediada porl el virus de la hepatitis c | |
PE20221083A1 (es) | Inhibidores de la autofagia de la amida aminopirimidina y sus metodos de uso | |
PE20220252A1 (es) | Compuestos de pirrol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |